Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $232.64.
Several analysts have commented on the company. JPMorgan Chase & Co. raised Axon Enterprise from a “neutral” rating to an “overweight” rating and set a $236.00 price objective for the company in a research note on Thursday, May 11th. Robert W. Baird upped their price objective on Axon Enterprise from $237.00 to $240.00 in a research note on Thursday, May 11th. StockNews.com assumed coverage on Axon Enterprise in a research note on Thursday, May 18th. They set a “hold” rating for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $240.00 price objective on shares of Axon Enterprise in a research note on Thursday, April 13th. Finally, TheStreet downgraded Axon Enterprise from a “b-” rating to a “c+” rating in a research note on Friday, May 26th.
Axon Enterprise Stock Down 0.9 %
Axon Enterprise stock opened at $178.30 on Tuesday. Axon Enterprise has a fifty-two week low of $97.86 and a fifty-two week high of $229.95. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.97 and a current ratio of 3.33. The company has a market capitalization of $13.17 billion, a P/E ratio of 94.34 and a beta of 0.90. The stock has a 50-day simple moving average of $194.13 and a 200-day simple moving average of $203.72.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Tuesday, May 9th. The biotechnology company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.48. Axon Enterprise had a return on equity of 10.65% and a net margin of 10.76%. The business had revenue of $343.04 million during the quarter, compared to the consensus estimate of $312.07 million. Equities research analysts expect that Axon Enterprise will post 1.58 earnings per share for the current year.
Insider Buying and Selling
In related news, Director Julie A. Cullivan sold 2,013 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $197.58, for a total value of $397,728.54. Following the sale, the director now owns 7,062 shares in the company, valued at approximately $1,395,309.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Axon Enterprise news, Director Julie A. Cullivan sold 2,013 shares of the stock in a transaction on Monday, May 22nd. The stock was sold at an average price of $197.58, for a total transaction of $397,728.54. Following the sale, the director now owns 7,062 shares in the company, valued at approximately $1,395,309.96. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua Isner sold 26,883 shares of the stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $193.10, for a total value of $5,191,107.30. Following the sale, the president now owns 290,965 shares in the company, valued at approximately $56,185,341.50. The disclosure for this sale can be found here. In the last quarter, insiders have bought 45,250 shares of company stock worth $8,735,200 and have sold 54,458 shares worth $10,534,340. Insiders own 6.10% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Hollencrest Capital Management purchased a new position in shares of Axon Enterprise during the 1st quarter worth $29,000. Spire Wealth Management purchased a new position in shares of Axon Enterprise in the 1st quarter worth $31,000. ICA Group Wealth Management LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth $25,000. WealthPLAN Partners LLC purchased a new position in shares of Axon Enterprise in the 1st quarter worth $35,000. Finally, U.S. Capital Wealth Advisors LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth $29,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Click the link below and we’ll send you MarketBeat’s list of seven best retirement stocks and why they should be in your portfolio.
